In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications

Endocrine Pathology

Volumn 26, Issue 2, 2015, Pages 157-163

  Guo, Zhenying ^a,e   Hardin, Heather ^a   Montemayor Garcia, Celina ^a   Asioli, Sofia ^b   Righi, Alberto ^c   Maletta, Francesca ^d   Sapino, Anna ^d   Lloyd, Ricardo V ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

Anaplastic thyroid carcinoma; Follicular variant papillary thyroid carcinomas; In situ hybridization; miR 146b 5p; miR 21; Papillary thyroid carcinoma

Indexed keywords

MICRORNA; MIRN146 MICRORNA, HUMAN; MIRN21 MICRORNA, HUMAN; TUMOR MARKER;

ADENOCARCINOMA; CARCINOMA; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METABOLISM; PATHOLOGY; PREDICTIVE VALUE; THYROID NODULE; THYROID TUMOR; TISSUE MICROARRAY;

ADENOCARCINOMA, FOLLICULAR; BIOMARKERS, TUMOR; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICRORNAS; PREDICTIVE VALUE OF TESTS; THYROID NEOPLASMS; THYROID NODULE; TISSUE ARRAY ANALYSIS;

EID: 84939995207     PISSN: 10463976     EISSN: 15590097     Source Type: Journal    
DOI: 10.1007/s12022-015-9363-x     Document Type: Article

References (32)

1. Siegel R, Naishadham D & Jemal A. Cancer statistics, CA Cancer J Clin 63:11–30, 2013.
2. Wiemer EA. The role of microRNAs in cancer: no small matter. Eur J Cancer 43:1529–44, 2007.
3. Gao Y, Wang C, Shan Z, Guan H, Mao J, Fan C, et al. miRNA expression in a human papillary thyroid carcinoma cell line varies with invasiveness. Endocr J 57:81–6, 2010.
4. Menon MP, Khan A. Micro-RNAs in thyroid neoplasms: molecular, diagnostic and therapeutic implications. J Clin Pathol 62:978–85, 2009.
5. Nikiforova MN, Chiosea SI, Nikiforov YE. MicroRNA expression profiles in thyroid tumors. Endocr Pathol 20:85–91, 2009.
6. Chou CK, Yang KD, Chou FF, et al. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma. J Clin Endocrinol Metab 98:E196-205, 2013.
7. Dettmer M, Perren A, Moch H, Komminoth P, Nikiforov YE, Nikiforova MN. Comprehensive microRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma. Thyroid. 23:1383–1389, 2013.
8. Frezzetti D, De Menna M, Zoppoli P, Guerra C, Ferraro A et al. Upregulation of miR-21 by Ras in vivo and its role in tumor growth. Oncogene 30:275–286, 2011.
9. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, et al. The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U SA 102:19075–19080, 2005.
10. Nikiforova MN, Tseng GC, Steward D, Diorio D & Nikiforov YE. MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab 93: 1600–1608, 2008.
11. Keutgen XM, Filicori F, Crowley MJ, Wang Y, Scognamiglio T, Hoda R, et al. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration. Clin Cancer Res 18: 2032–2038, 2012.
12. Wienholds E, Kloosterman WP, Miska E, Alvarez-Saavedra E, Berezikov E, de Bruijn et al. Science 309:310–311, 2005.
13. Ruebel K, Leontovich AA, Stilling GA, Zhang S, Righi A, Jin L, et al. MicroRNA expression in ileal carinoid tumors: downregulation of microRNA-133a with tumor progression. Mod Pathol 23:367–375, 2010.
14. Stilling G, Sun Z, Zhang S, Jin L, Righi A, Kovacs G, et al. MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas. Endocrine 38:67–75, 2010.
15. Buehler D, Hardin H, Shan W, Montemayor-Garcia C, Rush PS, Asioli S, Chen H, Lloyd RV. Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas. Mod Pathol 26:54–61, 2013.
16. Nielsen BS, Jorgensen S, Fog JU, Sokilde R, Christensen IJ, et al. High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis 28: 27–38, 2011.
17. Liu Y, Ding Y, Huang J, Wang S, Ni W, Guan J, et al. MiR-141 suppresses the migration and invasion of HCC cells by targeting Tiam1. PLoS One 9:e88393. 2014.
18. Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV, et al. Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res 67: 11612–11620, 2007.
19. Swierniak M, Wojcicka A, Czetwertynska M, Stachlewska E, Maciag M, Wiechno W, et al In-depth characterization of the microRNA transcriptome in normal thyroid and papillary thyroid carcinoma. J Clin Endocrinol Metab 98:E1401–1409, 2013
20. Zhang J, Liu Y, Liu Z, Wang XM, Yin DT, Zheng LL, et al. Differential expression profiling and functional analysis of microRNAs through stage I-III papillary thyroid carcinoma. Int J Med Sci. 10:585–592, 2013.
21. Pallante P, Visone R, Croce CM, Fusco A. Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas. Endocr Relat Cancer 17: F91–104, 2010.
22. Li Y, Wang Y, Yu L, Sun C, Cheng D, Yu S, et al. miR-146b-5p inhibits glioma migration and invasion by targeting MMP16. Cancer Lett 339:260–9, 2013.
23. Wu PY, Zhang XD, Zhu J, Guo XY, Wang JF. Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone. Hum Pathol 45:1664–1673, 2014.
24. Patnaik SK, Kannisto E, Mallick R, Yendamuri S. Overexpression of the lung cancer-prognostic miR-146b microRNAs has a minimal and negative effect on the malignant phenotype of A549 lung cancer cells. PLoS One 6(7):e22379, 2011.
25. Buisson M, Bertrand P, Rimokh R, Rouleau E, Lopez BS, et al Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers. Garcia AI1. EMBO Mol Med. 5:279–284, 2011.
26. Geraldo MV, Yamashita AS, Kimura ET. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer. Oncogene 31:1910–1922, 2011.
27. Zhang J, Yang Y, Liu Y, Fan Y, Liu Z, Wang X, et al MicroRNA-21 regulates biological behaviors in papillary thyroid carcinoma by targeting programmed cell death 4. J Surg Res 189:68–74, 2014.
28. Mitomo S, Maesawa C, Ogasawara S, Iwaya T, Shibazaki M, Yashima-Abo A, Izutsu N, et al. Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. Cancer Sci 99: 280–286, 2008.
29. Jazdzewski K, Boguslawska J, Jendrzejewski J, Liyanarachchi S, Pachucki J, Wardyn KA, et al. Thyroid hormone receptor {beta}(THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC). J Clin Endocrinol Metab 96:E546–53, 2010.
30. Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell 159: 676–690, 2014.
31. Hardin H, Guo Z, Shan W, Montemayor-Garcia C, Asioli S, Yu X-M, et al. The roles of the epithelial-mesenchymal transition marker PRRX1 and miR-146b-5p in papillary thyroid carcinoma progression. Am J Pathol 184:2342–2354, 2014
32. Nakamura N, Erickson LA, Jin L, Kajita S, Zhang H, Qian X, et al. Immunohistochemical separation of follicular variant of papillary thyroid carcinoma and follicular adenoma. Endocrine Pathol 17: 213–224, 2006.